Universal Beteiligungs und Servicegesellschaft mbH Takes Position in OrthoPediatrics Corp. (NASDAQ:KIDS)

Key Points

• Universal Beteiligungs und Servicegesellschaft mbH acquired 18,500 shares of OrthoPediatrics Corp. for approximately $456,000, representing about 0.08% ownership in the company.
• Research firms have varying opinions on OrthoPediatrics, with one firm maintaining a "buy" rating while others have adjusted their price targets, indicating a consensus rating of "Moderate Buy" with an average price target of $35.83.
• OrthoPediatrics reported (-$0.39) earnings per share in its latest quarterly earnings, missing the analysts' expectations, although its revenue of $52.41 million exceeded projections.

Universal Beteiligungs und Servicegesellschaft mbH acquired a new stake in OrthoPediatrics Corp. (NASDAQ:KIDS - Free Report) during the first quarter, according to its most recent disclosure with the SEC. The institutional investor acquired 18,500 shares of the company's stock, valued at approximately $456,000. Universal Beteiligungs und Servicegesellschaft mbH owned approximately 0.08% of OrthoPediatrics at the end of the most recent reporting period.

Several other large investors have also recently added to or reduced their stakes in KIDS. Invesco Ltd. increased its stake in OrthoPediatrics by 3.0% during the 4th quarter. Invesco Ltd. now owns 16,363 shares of the company's stock worth $379,000 after acquiring an additional 469 shares during the period. Northern Trust Corp lifted its holdings in shares of OrthoPediatrics by 0.3% during the 4th quarter. Northern Trust Corp now owns 193,798 shares of the company's stock worth $4,492,000 after acquiring an additional 644 shares during the period. Wells Fargo & Company MN lifted its stake in OrthoPediatrics by 31.1% during the fourth quarter. Wells Fargo & Company MN now owns 9,853 shares of the company's stock worth $228,000 after purchasing an additional 2,338 shares during the last quarter. American Century Companies Inc. increased its stake in shares of OrthoPediatrics by 13.2% in the 4th quarter. American Century Companies Inc. now owns 26,410 shares of the company's stock valued at $612,000 after purchasing an additional 3,072 shares during the last quarter. Finally, Barclays PLC boosted its stake in OrthoPediatrics by 12.2% in the fourth quarter. Barclays PLC now owns 28,390 shares of the company's stock valued at $658,000 after buying an additional 3,092 shares in the last quarter. Institutional investors own 69.05% of the company's stock.

OrthoPediatrics Stock Up 0.7%

KIDS stock traded up $0.14 during mid-day trading on Monday, reaching $20.53. 245,400 shares of the company traded hands, compared to its average volume of 152,337. The stock has a market cap of $498.67 million, a price-to-earnings ratio of -11.73 and a beta of 1.12. OrthoPediatrics Corp. has a fifty-two week low of $19.51 and a fifty-two week high of $33.14. The firm's 50 day moving average price is $21.50 and its 200 day moving average price is $22.80. The company has a quick ratio of 2.99, a current ratio of 6.19 and a debt-to-equity ratio of 0.21.

OrthoPediatrics (NASDAQ:KIDS - Get Free Report) last released its quarterly earnings results on Wednesday, May 7th. The company reported ($0.39) EPS for the quarter, missing analysts' consensus estimates of ($0.26) by ($0.13). OrthoPediatrics had a negative net margin of 19.15% and a negative return on equity of 7.03%. The company had revenue of $52.41 million during the quarter, compared to analysts' expectations of $51.68 million. As a group, equities research analysts predict that OrthoPediatrics Corp. will post -0.93 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Several analysts have recently weighed in on the company. Truist Financial reduced their price target on OrthoPediatrics from $26.00 to $24.00 and set a "hold" rating on the stock in a report on Friday, April 11th. Lake Street Capital started coverage on shares of OrthoPediatrics in a research note on Monday, April 7th. They set a "buy" rating and a $37.00 price target for the company. BTIG Research reiterated a "buy" rating on shares of OrthoPediatrics in a report on Monday, July 14th. Wall Street Zen downgraded OrthoPediatrics from a "hold" rating to a "sell" rating in a report on Friday, July 18th. Finally, Needham & Company LLC reaffirmed a "buy" rating and set a $42.00 target price on shares of OrthoPediatrics in a research report on Thursday, May 8th. One investment analyst has rated the stock with a sell rating, one has given a hold rating and six have given a buy rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $35.83.

About OrthoPediatrics

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products.